Skip to main content
. 2020 May 28;41(12):3625–3632. doi: 10.1007/s10072-020-04474-7

Fig. 3.

Fig. 3

Progression-free survival of patients with maximal tumor perfusion above (gray) and below (black) the cutoff value in IDH-mutant astrocytic tumors (a), IDH wild-type astrocytic tumors (b), and oligodendrogliomas (c)